Latest News

Genetic evidence that new therapies targeting Parkinson's disease may cause harm

Researchers have completed a small study that shows genetic and clinical evidence that therapies targeting the expression of alpha-synuclein -- a gene whose function is involved in the development and progression of Parkinson?s disease -- may accelerate disease progression and increase the risk of physical incapacitation and dementia. If replicated, the findings will have profound implications for therapies under development for Parkinson?s disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • A football helmet design that listens to physics

  • 'Pushback' against constant connectivity also reflected in images

  • Does shopping helps you feel better after a setback?

  • The significance of non-motor microtubule-associated protein in maintaining synaptic plasticity thorough a novel mechanism

  • Parental preference for boys damages girls? self-esteem and happiness

  • Scientists discover molecular link between psychiatric disorders and type 2 diabetes

  • Head injury patients develop brain clumps associated with Alzheimer?s disease

  • Neurobiological changes explain how mindfulness meditation improves health

  • Athlete passion linked to acceptance of performance enhancing drugs

  • Mesh-like scaffold is disordered in Alzheimer's-affected cells

  •